Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today announced SFDA (Saudi Food and Drug Authority) approval of sugarBEAT(R), its non-invasive wearable glucose sensor. According to the update, the news comes after a year of liaisons with the SFDA … Continue reading InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures SFDA Approval for sugarBEAT(R)